Three things to know:
1. The compound annual growth rate for the orthopedic regenerative surgical product market is forecast to rise 3.9 percent between 2022 and 2030, according to an April 21 news release.
2. Key market growth drivers include the rising aging population, research and development in regenerative medicine and growing need for orthopedic care.
3. Market players named in the report include Zimmer Biomet, Stryker, Smith+Nephew and Allosource.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
